Clinical Trial

Adrenal Tumors - Pathogenesis and Therapy

Recruiting
View on ClinicalTrials.gov →
Summary
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2008-04-29; most recent amendment 2026-05-01.
Trial Details
NCT Number NCT00669266
Lead Sponsor University of Wuerzburg
Collaborators: Deutsche Krebshilfe e.V., Bonn (Germany), German Federal Ministry of Education and Research
Conditions Adrenal Tumors, Adrenocortical Carcinoma, Cushing Syndrome, Conn Syndrome, Pheochromocytoma
Enrollment 500 participants
Start Date 2002-09
Primary Completion 2030-12 (estimated)
Study Completion 2032-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-07